Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and ...

GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.

A Scottish drug device specialist has secured a £1.5 million cash injection to drive development of its pop-up cardboard ...

GPs have been advised to stop prescribing blue reliever inhalers alone for newly-diagnosed asthma. Instead, they should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to ...